Evaluation of the effect of herbal therapeutic supplements (Marsh - Mallow, Sweet violet, Malva sylvestris, Damask rose, Liquorice root) against corona disease

Phase 2

• Conditions: COVID-19.; COVID-19, virus identified; U07.1

• Registration Number: IRCT20210325050769N1
• Lead Sponsor: Bagheiat-allah University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 April 2021

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

Diagnosis of COVID-19
Age 18-65
Having informed and written consent to participate in the study

Exclusion Criteria

Disagreement of the physician directly responsible for the patient
Pregnancy and breastfeeding
Allergies to the drug elements
Symptoms of gastrointestinal, liver or kidney disease
Incidence of drug interactions
Patient dissatisfaction to continue the project for any reason
Inability of the patient to receive oral medication
Hypertension
Having heart failure
Do not take anticoagulants (aspirin, Plavix, warfarin)

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Hospitalization time. Timepoint: Before starting the study and after 5 days of using herbal supplements. Method of measurement: A researcher-made questionnaire whose validity and reliability have been assessed.